Alice Saber Gerges <br/><br/>
Glypican 3 as a novel marker for Hepatocellular carcinoma /  
 الجليبكان 3 كدلالة جديدة للورم السرطانى بالكبد 
Alice Saber Gerges ; Supervised Inas Ismail Raafat , Eman El-Ghroury , Mai Mahmoud Sherif 
 - Cairo :   Alice Saber Gerges ,   2013 
 - 180 P. :   charts ;   25cm 
<br/><br/>Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology 
<br/><br/> Most of patients with HCC are diagnosed at a late stage. Therefore, the prognosis of HCC patients is generally very poor. Alpha.fetoprotein has been widelly used , but its sensitivity has not been satisfactory , in addition to its non-specific elevation innon malignant hepatic diseases. Glypican 3, this protein(GPC3) is over-expressed in HCC, and not in normal hepatocytes and non-malignant liver disease. 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Glypican 3  Hepatocellular carcinoma  Real time PCR